quercetin

Small moleculeexperimental

Quercetin is a unique bioflavonoid that has been extensively studied by researchers over the past 30 years. Quercetin, the most abundant of the flavonoids (the name comes from the Latin –quercetum, meaning oak forest, quercus oak) consists of 3 rings and 5 hydroxyl groups. Quercetin is a member of the class of flavonoids called flavonoles and forms the backbone for many other flavonoids including the citrus flavonoids like rutin, hesperidins, Naringenin and tangeritin. It is widely distributed in the plant kingdom in rinds and barks. The best described property of Quercetin is its ability to act as antioxidant. Quercetin seems to be the most powerful flavonoids for protecting the body against reactive oxygen species, produced during the normal oxygen metabolism or are induced by exogenous damage [9, 10]. One of the most important mechanisms and the sequence of events by which free radicals interfere with the cellular functions seem to be the lipid peroxidation leading eventually the cell death. To protect this cellular death to happen from reactive oxygen species, living organisms have developed antioxidant line of defense systems [11]. These include enzymatic and non-enzymatic antioxidants that keep in check ROS/RNS level and repair oxidative cellular damage. The major enzymes, constituting the first line of defence, directly involved in the neutralization of ROS/RNS are: superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) The second line of defence is represented by radical scavenging antioxidants such as vitamin C, vitamin A and plant phytochemicals including quercetin that inhibit the oxidation chain initiation and prevent chain propagation. This may also include the termination of a chain by the reaction of two radicals. The repair and de novo enzymes act as the third line of defence by repairing damage and reconstituting membranes. These include lipases, proteases, DNA repair enzymes and transferases. Quercetin is a specific quinone reductase 2 (QR2) inhibitor, an enzyme (along with the human QR1 homolog) which catalyzes metabolism of toxic quinolines. Inhibition of QR2 in plasmodium may potentially cause lethal oxidative stress. The inhibition of antioxidant activity in plasmodium may contribute to killing the malaria causing parasites. — NCATS

Clinical trial activity

92 trials · 106 clinical orgs · 0 marketing orgs

Phase 1
28
Phase 2
38
Phase 3
3
Phase 4
5

Earliest trial started Aug 1, 1996 (NCT00003365)

Timeline

2000s

  1. Jan 1, 2006

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2009

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2019

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • Unspecified targetAntioxidant

    antioxidant

Chemistry & pharmacology

Loading structure…

SMILES

O.O.OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C3=CC=C(O)C(O)=C3
Mol. weight
338.2663 g/mol
Lipinski Ro5
2 violation(s)
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 3,3',4',5,7-pentabenzyloxyflavone
  • 3,5,7,3',4'-pentahydroxyflavone
  • 3,5,7,3',4'-pentahydroxyflavone
  • benzquercin
  • benzquercin
  • benzquercin
  • benzquercin
  • benzquercine
  • parietrope
  • potassium quercetin phosphate
  • qr-333
  • quercetin
  • quercetin
  • quercetin
  • quercetin
  • quercetin
  • quercetin
  • quercetin
  • quercetin-3'-o-phosphate
  • quercetine
  • quercetin pentabenzyl ether
  • quercetol
  • quertine
  • xanthaurine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07270120Phase 1Jan 15, 2026Ohio State University
NCT07144293Phase 2Oct 15, 2025National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Aging (NIA)
NCT07182526Phase 2Sep 20, 2025Al-Mustansiriyah University
NCT07025226Early Phase 1 (Phase 1)Aug 12, 2025Mayo Clinic
NCT07000734Phase 2Jul 31, 2025Washington University in St. Louis
NCT06974058N/AJul 22, 2025Liaquat University of Medical & Health Sciences
NCT06940297Phase 2Jun 23, 2025Mayo Clinic, National Cancer Institute (NCI)
NCT06796374N/AFeb 1, 2025University of Greifswald
NCT06683534N/AJan 31, 2025Medical College of Wisconsin
NCT06615752Phase 1/Phase 2 (Phase 2)Nov 30, 2024Charles Drew University, National Institutes of Health (NIH)
NCT06650891Phase 3Oct 31, 2024Future University in Egypt
NCT06982248Phase 2Aug 15, 2024Mansoura University
NCT06470061Phase 2Jul 31, 2024Northwestern University, Zaparackas and Knepper LTD
NCT06355037Phase 2May 20, 2024Fudan University
NCT06230861N/AMar 1, 2024University of Central Lancashire
NCT06775392Phase 1Jan 4, 2024Krishnadevaraya College of Dental Sciences & Hospital
NCT05928546Phase 1Oct 20, 2023Assiut University
NCT06591767N/AOct 1, 2023Liaquat University of Medical & Health Sciences, University of Urbino "Carlo Bo"
NCT06003270Phase 2Sep 30, 2023National Center for Complementary and Integrative Health (NCCIH), National Institutes of Health (NIH), Quercegen Pharmaceuticals, Temple University
NCT06018467Phase 2Sep 6, 2023Novo Nordisk, University of Southern Denmark
Showing 20 of 92 trials
Page 1 / 5

Organizations

Research & Development (106)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Mayo ClinicAcademic/Hospital9632016
National Institutes of Health (NIH)Government6022010
Quercegen PharmaceuticalsFor profit5032009
National Cancer Institute (NCI)Government4031996
University of PaviaAcademic/Hospital4322017
Harvard UniversityAcademic/Hospital3322009
Liaquat University of Medical & Health SciencesAcademic/Hospital3322020
National Center for Complementary and Integrative Health (NCCIH)Government3022014
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Government3122010
National Institute on Aging (NIA)Government3022009
Wake Forest UniversityAcademic/Hospital3332016
Assiut UniversityAcademic/Hospital2222022
Government of Saudi ArabiaGovernment2222020
Hôpital Universitaire SahloulAcademic/Hospital2212021
King Edward Medical UniversityAcademic/Hospital2212021
Mashhad University of Medical SciencesAcademic/Hospital2222010
Temple UniversityAcademic/Hospital2212019
University of California, Los AngelesAcademic/Hospital2212011
University of CincinnatiAcademic/Hospital2222012
University of Sao PauloAcademic/Hospital2222019
106 organizations
Page 1 / 6